Biological quantitative methods in the evaluation of psychiatric treatment: some biochemical criteria.
D000929:Antidepressive Agents, Tricyclic / Q000097:blood / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002394:Catechol O-Methyltransferase / Q000097:blood; D004565:Electroconvulsive Therapy; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008094:Lithium / Q000627:therapeutic use; D008734:Methoxyhydroxyphenylglycol / Q000652:urine; D008995:Monoamine Oxidase / Q000097:blood; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D019964:Mood Disorders / Q000188:drug therapy* / Q000201:enzymology; D018377:Neurotransmitter Agents / Q000378:metabolism*; D011379:Prognosis; D012559:Schizophrenia / Q000188:drug therapy / Q000201:enzymology
D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D008996:Monoamine Oxidase Inhibitors; D018377:Neurotransmitter Agents; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D008094:Lithium; D008995:Monoamine Oxidase; D002394:Catechol O-Methyltransferase